SOVREMENNAYA PEDIATRIYA.2018.1(89):45-50

Nikiforova G. N., Svistushkin V. M., Bidanova D. B., Volkova K. B.
First Moscow State Medical University named after I.M. Sechenov
*Published: Meditsinskiy sovet. 2017. 8: 24—28.

Infectious-inflammatory diseases of the pharynx are the most common pathological processes in the human population. Correct diagnosis and rational choice of effective treatment are directly correlate with important role of the pharyngeal tube in the life of the organism and a high risk of complications. The vast majority of clinical cases do not require the use of systemic drugs, topical therapy only. However, in the light of new data on the importance of microbial populations (microbiome), working as a functional barrier between the environment and nasopharyngeal mucosa, attention is attracted to topical antiseptics with antiinflammatory and biocenose saving effects, as part of complex therapy in diseases of the throat In the light of this issue, topical drugs based on lysozyme — an enzyme, which is a natural antiseptic for the human body, are looking promising. These products are represented by Lysobact® (Bosnalijek, Bosnia and Hercegovina). It has proven anti1inflammatory, immunomodulatory and antiseptic action, and it`s efficacy is meaningful in treatment of the pharynx diseases in patients of different age groups.

Key words: Infectious1inflammatory diseases of the pharynx functions of the pharynx, the factors of natural protection, tonsillopharyngitis, lysozyme, Lysobact®.

References

1. Ryazantsev S.V., Kocherovets V.I. (2008). Etiopatogeneticheskaya terapiya zabolevaniy verhnih dyihatelnyih putey i uha. Metodicheskie rekomendatsii. SPb.: 98.

2. Differentsialnaya diagnostika i lechenie ostrogo tonzillfaringita. Klinicheskie rekomendatsii. Moskva. http://glav-otolar.ru/wp-content/uploads/2015/02/KR-O. Tonzillofaringit-utverzhdennyiy.doc. http://onlinelibrary.wiley.com/doi/10.1002/14651858. CD008911.pub2/full.

3. Palchun V.T. i dr. (2008). Otorinolaringologiya. Natsionalnoe rukovodstvo. Pod red. V.T. Palchuna. M.: GEOTAR-Media: 960.

4. Turovskiy A.B., Talalayko Yu.V. (2011), Medikamentoznaya terapiya ostryih vospalitelnyih zabolevaniy glotki. RMZh. 24: 1501—1505.

5. Nikiforova G.N., Zolotova A.V., Svistushkin M.V. (2015). Bol v glotke: prichinyi vozniknoveniya i sposobyi lecheniya. Farmateka: k kongressu «Chelovek i lekarstvo». 6: 25—29.

6. ESCMID Sore Throat Guideline Group. Guideline for the management of acute sore throat. Clin Microbiol Infect., 2012 Apr, 18.

7. Vicedomini D, Lalinga G, Lugli N, D'Avino A. (2014, Feb). Diagnosis and management of acute pharyngotonsillitis in the primary care pediatrician's office. Minerva Pediatr. 66(1): 69—76.

8. Byikova V.P., Satdyikova G.P. (2002). Morfofunktsionalnaya organizatsiya limfoepitelialnyih organov glotki cheloveka. Izvestiya AN. Seriya biologicheskaya. 4: 463—471.

9. Arefeva N.A. (2012). Tonzillyarnaya patologiya. Sovremennoe sostoyanie problemyi. Vestnik otorinolaringologii. 6: 10—13.

10. Yulish E.I. (2010). Faktoryi mestnogo immuniteta pri respiratornyih infektsiyah i metodyi ih aktivatsii. Zdorove rebenka. 5: 63—67.

11. Cots JM, Alos JI, Barcena M, Boleda X, Canada JL, Gomez N, Mendoza A, Vilaseca I, Llor C. (2016, Nov). Recommendations for management of acute pharyngitis in adults. Enferm Infecc Microbiol Clin. 34(9): 585—594. https://doi.org/10.1016/j.eimc.2015.02.010; PMid:25869058

12. Gwaltney JM. In: Mandell G. L, Bennet J. E., Dolin R. eds. (1995). Principles and practice of infectious diseases. New York.

13. Dajani R, Zove S, Taft P. (2005). Lisozime secretion by submucoasal glands protects the airway from bacterial. Ann. J. Res. Cell Mol. Biol. 32(6): 548—552. https://doi.org/10.1165/rcmb.2005-0059OC; PMid:15746432 PMCid:PMC2715323

14. Instruktsiya k meditsinskomu primeneniyu preparata Lizobakt. http://lisobact.ru/.

15. Chernyshov AV, Melnicov OF. (1992). Tonsillar lymphocyte subsets in tonsillitis and hyperplasia. 7th Internat Congress of Mucosal Immunology (Prague, Czechoslovakia, August 16—20, 1992). Abstr. Prague. 41.

16. Pogorelova O.O., Usenko D.V., Ardatskaya M.D., Dikaya A.V., Gorelov A.V. (2009). Otsenka effektivnosti Lizobakta v lechenii ostrah respiratornyih zabolevaniy u detey. Infektsionnyie bolezni. 7(1): 69—72.